Cover Image


View/Hide Left Panel


Ross Pierce, M.D.

(Medical Officer, Clinical Investigations Branch, Division of Scientific Investigations, Office of Compliance, (CDER), U.S. Food and Drug Administration)

12:00 Noon

Luncheon Buffet, Meeting Room 2004

1:00 p.m.

Report of the FDA Task Force on Fialuridine: Hepatic and Pancreatic Toxicity


Roger L. Williams, M.D.

(Associate Director for Science and Medical Affairs, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration)

2:00 p.m.

Role of the Division of Anti-Vital Drug Products


David Feigal, M.D.

(Director, Division of Anti-Viral Drug Products, Office of Drug Evaluation, CDER, U.S. Food and Drug Administration)

3:15 p.m.


3:30 p.m.

Review of Studies R91-010 and PPPC


Jay H. Hoofnagle, M.D.

(Director, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health)

5:00 p.m.

Meeting Adjourns for the Day

TUESDAY, July 26, 1994

8:00 a.m.

Review of Studies R89-001 and R90-001


Lawrence Corey, M.D.

(Professor, Laboratory Medicine, Microbiology and Medicine, Virology Office, University of Washington, Seattle)

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement